Abcm Corporation (ABCM): Price and Financial Metrics

Abcm Corporation (ABCM): $14.56

-0.42 (-2.80%)

POWR Rating

Component Grades














  • Sentiment is the dimension where ABCM ranks best; there it ranks ahead of 89.76% of US stocks.
  • The strongest trend for ABCM is in Momentum, which has been heading down over the past 179 days.
  • ABCM ranks lowest in Momentum; there it ranks in the 14th percentile.

ABCM Stock Summary

  • Abcam plc's stock had its IPO on October 22, 2020, making it an older stock than merely 2.29% of US equities in our set.
  • With a price/earnings ratio of 720.99, Abcam plc P/E ratio is greater than that of about 98.97% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for ABCM is currently 59.38, higher than 91.67% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to Abcam plc, a group of peers worth examining would be FTEK, IOSP, OFLX, MGIC, and ENZ.
  • To dig deeper into the stock's financial statements, go to ABCM's page on browse-edgar?action=getcompany&CIK=0001492074.

ABCM Stock Price Chart Interactive Chart >

Price chart for ABCM

ABCM Price/Volume Stats

Current price $14.56 52-week high $24.00
Prev. close $14.98 52-week low $12.54
Day low $14.56 Volume 57,800
Day high $14.91 Avg. volume 150,541
50-day MA $14.84 Dividend yield N/A
200-day MA $18.75 Market Cap 3.33B

Abcm Corporation (ABCM) Company Bio

Abcm Corporation operates rehabilitation centers, long-term care facilities, and independent and assisted living communities. The Company offers out-patient therapy, independent and assisted living, skilled nursing and rehabilitative care, dementia care, family respite care, respite services, and home care. ABCM serves patients throughout the United States.

ABCM Latest News Stream

Event/Time News Detail
Loading, please wait...

ABCM Latest Social Stream

Loading social stream, please wait...

View Full ABCM Social Stream

Latest ABCM News From Around the Web

Below are the latest news stories about Abcam plc that investors may wish to consider to help them evaluate ABCM as an investment opportunity.

Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications

CAMBRIDGE, England & SOUTH SAN FRANCISCO, Calif., February 01, 2022--Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announced a licensing agreement under which Abcam will use a proprietary Twist VHH phage library for antibody discovery, development and commercialization for diagnostic an

Yahoo | February 1, 2022

Is Abcam plc (LON:ABC) Trading At A 20% Discount?

Today we will run through one way of estimating the intrinsic value of Abcam plc ( LON:ABC ) by projecting its future...

Yahoo | January 9, 2022

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences research tools, today announced a strategic partnership to further understanding of the human proteome.

Yahoo | January 4, 2022

Immunoprotein Diagnostic Testing Market Is Booming Worldwide 2021-2028 | Abbott Laboratories, Inc., Abcam PLC, Agilent Technologies

Another factual information on the "Immunoprotein Diagnostic Testing Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the

OpenPR | December 24, 2021

Bradycardia Drugs Market Report: Production Capacity And Consumption Analysis By Regions And Country Wise Forecast Report 2022-2027 | Alkaloids of Australia, Abcam, Albany Molecular Research, Alchem International

Los Angeles, United State, ,- This research study is one of the most detailed and accurate ones that solely focus on the global Bradycardia Drugs market. It sheds light on critical factors that impact the growth of the global Bradycardia

OpenPR | December 23, 2021

Read More 'ABCM' Stories Here

ABCM Price Returns

1-mo N/A
3-mo -20.39%
6-mo -38.17%
1-year -25.45%
3-year N/A
5-year N/A
YTD -38.17%
2021 9.28%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4663 seconds.